Voriconazole 200mg Tablet | VINOCANAZOL 200

Description

Voriconazole 200mg Tablet VINOCANAZOL 200 is a potent antifungal medication containing Voriconazole 200 mg as its active ingredient. Developed and manufactured by Steris Healthcare Pvt. Ltd., this advanced antifungal agent is widely prescribed for the treatment of serious fungal infections caused by susceptible strains of fungi, including Aspergillus and Candida species. Voriconazole belongs to the triazole class of antifungal medicines, which work by inhibiting fungal cell membrane formation. This mechanism effectively halts the growth and spread of fungal infections in the body. VINOCANAZOL 200 is trusted by healthcare professionals for treating both systemic and invasive fungal infections, particularly in patients with weakened immune systems or those undergoing chemotherapy, organ transplants, or long-term antibiotic therapy. With proven clinical efficacy and high tolerability, VINOCANAZOL 200 offers a reliable solution for managing complex fungal infections and ensuring faster recovery. Uses VINOCANAZOL 200 (Voriconazole 200 mg) is indicated for the treatment of a wide range of fungal infections, including: Invasive Aspergillosis: A serious infection caused by Aspergillus species, often affecting the lungs. Candidemia: Fungal infection of the bloodstream caused by Candida species. Esophageal and Disseminated Candidiasis: Fungal infections affecting the mouth, throat, or internal organs. Fusariosis and Scedosporiosis: Rare but severe fungal infections resistant to conventional antifungal therapies. Fungal Infections in Immunocompromised Patients: Effective in preventing and treating fungal infections in patients with reduced immunity, such as those with HIV/AIDS, cancer, or after organ transplantation. By targeting fungal infections at their source, VINOCANAZOL 200 helps restore health and prevents further complications. Benefits Broad-Spectrum Antifungal Action: Effective against a variety of resistant fungal strains. Fast and Reliable Results: Provides quick relief by inhibiting fungal growth and replication. Clinically Proven Formula: Contains Voriconazole 200 mg, a globally trusted antifungal ingredient. Improves Recovery in Critical Cases: Especially beneficial for immunocompromised patients. Excellent Oral Bioavailability: Ensures optimal absorption and consistent blood levels for maximum effectiveness. Trusted Quality: Manufactured by Steris Healthcare Pvt. Ltd. under strict quality and safety standards. VINOCANAZOL 200 ensures reliable treatment outcomes, particularly in cases where other antifungal medicines fail to provide sufficient response. Dosage Recommended Adult Dose: The usual dosage is Voriconazole 200 mg twice daily (every 12 hours), taken orally or as prescribed by the doctor. Administration Guidelines: Take VINOCANAZOL 200 one hour before or one hour after meals for best absorption. Swallow the tablet whole with water. Always complete the full course of treatment, even if symptoms improve early. Dosage Adjustment: The dosage may vary depending on the infection type, severity, and patient’s medical condition. Pediatric or liver-impaired patients require special dose adjustments under medical supervision. Never self-medicate or alter the prescribed dosage without consulting your healthcare professional. Side Effects While VINOCANAZOL 200 is generally well-tolerated, some patients may experience mild to moderate side effects, including: Nausea or vomiting Headache or dizziness Blurred vision or sensitivity to light (temporary) Skin rash or itching Elevated liver enzyme levels Serious side effects such as liver dysfunction, allergic reactions, or visual disturbances are rare but require immediate medical attention. Regular liver function tests are recommended during prolonged therapy. Conclusion VINOCANAZOL 200 (Voriconazole 200 mg) by Steris Healthcare Pvt. Ltd. is a powerful, broad-spectrum antifungal medication designed to treat life-threatening fungal infections effectively. With its proven mechanism of action, strong bioavailability, and clinical reliability, it remains a trusted choice among healthcare providers for managing severe fungal infections in both hospitalized and outpatient settings.